TradeOrgs
  • Stocks
  • Screener
  • Backtest
  • Watchlist
  • Signals
  • Portfolio
  • Insights
  • Connect
Sign in
RELIANCE₹1,304.00▼ 0.70%TCS₹2,093.50▼ 6.61%HDFCBANK₹801.05▲ 6.29%ICICIBANK₹1,411.40▲ 13.64%INFY₹1,047.20▼ 14.35%HINDUNILVR₹2,201.20▲ 5.29%ITC₹289.95▲ 4.68%SBIN₹1,040.00▲ 7.17%BHARTIARTL₹1,910.40▲ 4.73%KOTAKBANK₹396.75▲ 4.13%LT₹4,026.60▲ 1.86%AXISBANK₹1,342.10▲ 6.92%ASIANPAINT₹2,737.80▲ 2.83%MARUTI₹14,366.00▲ 10.13%AAPL$308.63▼ 2.08%MSFT$390.49▼ 11.52%GOOGL$359.91▼ 0.54%AMZN$242.67▼ 5.40%NVDA$194.83▼ 12.56%META$582.90▼ 2.46%TSLA$393.45▼ 7.15%BRK-B$507.78▲ 7.69%JPM$334.47▲ 11.13%V$362.13▲ 14.12%
RELIANCE₹1,304.00▼ 0.70%TCS₹2,093.50▼ 6.61%HDFCBANK₹801.05▲ 6.29%ICICIBANK₹1,411.40▲ 13.64%INFY₹1,047.20▼ 14.35%HINDUNILVR₹2,201.20▲ 5.29%ITC₹289.95▲ 4.68%SBIN₹1,040.00▲ 7.17%BHARTIARTL₹1,910.40▲ 4.73%KOTAKBANK₹396.75▲ 4.13%LT₹4,026.60▲ 1.86%AXISBANK₹1,342.10▲ 6.92%ASIANPAINT₹2,737.80▲ 2.83%MARUTI₹14,366.00▲ 10.13%AAPL$308.63▼ 2.08%MSFT$390.49▼ 11.52%GOOGL$359.91▼ 0.54%AMZN$242.67▼ 5.40%NVDA$194.83▼ 12.56%META$582.90▼ 2.46%TSLA$393.45▼ 7.15%BRK-B$507.78▲ 7.69%JPM$334.47▲ 11.13%V$362.13▲ 14.12%

TradeOrgs shows market information and analyzes your own trading history. It does not place trades and is not investment advice.

Prices and listings are for information only. We are read-only against your broker account.

Technical signals (RSI, MACD, etc.) are educational readouts of public indicators — not recommendations.

Privacy Policy·© 2026 TradeOrgs

← All stocks

🇺🇸AIMDW

Ainos, Inc. - warrants

NASDAQ
$0.15
▲ $0.05 (+47.0%)
Live· just now
delayed feed · not for order timing

Price history · 20-day (cyan) / 50-day (purple) avg

as of 01 Jul 2026
H $0.13L $0.10-22.2%
$0.13$0.12$0.12$0.11$0.11$0.1$0.1
RSI (14)
Intraday · 15-minBuy+15RSI 61UptrendMACD Bearishfor day-trading context — not advice

Technical signal

Neutral0
RSI (14)0
oversold 30overbought 70
Trend
Sideways
MACD
Bullish
Bollinger
Within bands
vs 20-day
above
vs 50-day
above
vs 200-day
—
Support
$0.10
Resistance
$0.10
  • Price is below its 50-day average (medium-term weakness).
  • RSI is 0 — oversold, a level some traders read as a potential entry zone.

About Ainos, Inc.

source: yahoo

Ainos, Inc., a dual-platform company, focusing artificial intelligence–based smelltech technologies and immune therapeutics. It offers AI Nose, an AI-based electronic olfaction system, which uses a smell language model to digitize scent into Smell IDs and turning into machine-readable data. The company provides its platforms for semiconductor manufacturing, robotics, and smart manufacturing industries; as well as senior care and women's health sectors. In addition, it develops VELDONA, a low-dose oral interferon platform for human and animal health applications, targeting rare, autoimmune, and infectious diseases. The company was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. Ainos, Inc. was incorporated in 1984 and is based in Houston, Texas. Ainos, Inc. is a subsidiary of Taiwan Carbon Nano Technology Corporation.

Employees
41
Headquarters
Houston, United States
www.ainos.com ↗

Fundamentals· Automobiles

demo data

Live data was unavailable (the free feed can be rate-limited or blocked by region/host), so sample figures are shown. Set FINNHUB_API_KEY for a reliable fallback.

Market cap
$850.17B
P/E
23.8
P/B
2.0
EPS
$8.00
Div yield
1.6%
Profit margin
17.2%
ROE
8.2%
Debt / Equity
0.22
Beta
1.43
52-week range
$133.34 – $238.10
52-week low · $133.340% of rangehigh · $238.10

Recent news

News sentiment:▲ Positive5↑ · 0↓ · 3–
  • Interview with Jack Lu, Head of Corporate Development of Ainos, Inc.— Neutral
    Zacks Small Cap Research · 29 Jun 2026
  • VASRO Research Highlights Ainos' Expansion of Smell AI Into Patient-Level Breath Intelligence▲ Positive
    ACCESS Newswire · 22 Jun 2026
  • Ainos Expands Smell AI Platform into Digital Breath Intelligence Through National Taiwan University Research Program▲ Positive
    ACCESS Newswire · 17 Jun 2026
  • Ainos Releases 2026 Mid-Year CEO Letter to Shareholders

Educational technical indicators — not investment advice. TradeOrgs does not place trades.

Fundamental data is informational only — not investment advice.

— Neutral
ACCESS Newswire · 08 Jun 2026
  • VASRO Research Highlights Ainos Smell AI Expansion into Emergency Department Operations▲ Positive
    ACCESS Newswire · 05 Jun 2026
  • Zacks SCR Discusses Ainos' Expansion of Smell AI into Healthcare Infrastructure Through NTUH Study▲ Positive
    ACCESS Newswire · 03 Jun 2026
  • Sentiment is a keyword-based read of the headline — a rough signal, not advice.